Lanean...
Are selective COX 2 inhibitors superior to traditional NSAIDs? : Rofecoxib did not provide unequivocal benefit over traditional NSAIDs
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2002
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1123680/ https://ncbi.nlm.nih.gov/pubmed/12130617 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|